Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other Working Capital Changes of $18000.0 for Q1 2026, up 154.55% year-over-year from $7071.4 in Q1 2025, and down 96.47% quarter-over-quarter from $510000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other Working Capital Changes for 7 consecutive years, with $18000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 154.55% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $106000.0 (up 180.3% YoY), while the FY2025 annual figure was $55000.0, up 142.64% from the prior year.
- Other Working Capital Changes retreated to $18000.0 in Q1 2026 per VVOS's latest filing, from $510000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $680000.0 in Q1 2022 and bottomed at -$667000.0 in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$37882.4 across 5 years, with a median of -$102000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 9950.0% — and 2024, when it tumbled 825.93%.
- Vivos Therapeutics' Other Working Capital Changes stood at $456000.0 in 2022, then tumbled by 30.92% to $315000.0 in 2023, then surged by 155.87% to $806000.0 in 2024, then sank by 36.72% to $510000.0 in 2025, then plunged by 96.47% to $18000.0 in 2026.
- Business Quant data shows VVOS's Other Working Capital Changes at $18000.0 in Q1 2026, $510000.0 in Q4 2025, and $53000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.93 Mn | 3.13 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166,000.00 |
| Mar 31, 2026 | 166,000.00 |
| Mar 31, 2026 | 166,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | -236,000.00 |
| Mar 31, 2025 | -236,000.00 |
| Mar 31, 2025 | -236,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |